FDA.reportPublic FDA data

NeobryXol Forte

Manufacturer
Bryomed Inc. | King Bio Inc.
Effective date
2012-04-05
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 02:03:43

Label at a glance#

ProductNeobryXol Forte
Active ingredientASTERIAS RUBENS, BRYONIA ALBA ROOT, CONIUM MACULATUM FLOWERING TOP, STRYCHNOS WALLICHIANA BARK, GALIUM APARINE, LACHESIS MUTA VENOM, STRYCHNOS NUX-VOMICA SEED, EGG SHELL, COOKED, SEPIA OFFICINALIS JUICE, VISCUM ALBUM WHOLE
Label structure8 sections

Indications and uses

Indication: Maintains the system under the stress of malignancy regardless of location. Targets tissues that tend to be more susceptible to cancer, neuralgias and dropsy of extremities, yellowed skin, headache, physical weakness and rheumatic pains. Based on the homeopathic Materia  Medicas. Reference image forte.jpg

Dosage and administration

Directions: Two complete sprays under the tongue, between meals, 3 times a day. Reference image forte.jpg

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Official HPUS: Asterias rubens, Bryonia, Conium maculatum, Galium aparine, Hoang-nan, Lachesis mutus, Nux vomica, Ova tosta, Sepia and Viscum album.

Reference image forte.jpg

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Equal volumes of each ingredient in a Bio-Energetically enhanced pure water base: 10X, 100X, LM1 potency. Inactive ingredients: pure water and alcohol.

Reference image forte.jpg

                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

Purpose

OTC - PURPOSE SECTION

Indication: maintains the system under the stress of malignancy regardless of location. Targets tissues that tend to be more susceptible to:

  • cancer
  • neuralgias
  • dropsy of extremities
  • yellowed skin
  • headache
  • physical weakness
  • rheumatic pains
Based on the homeopathic Materia  Medicas.

Reference image forte.jpg

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

Directions: Two complete sprays under the tongue, between meals, 3 times a day.

Reference image forte.jpg

Warnings

WARNINGS SECTION

Warnings: If symptoms persist or worsen, seek advice of physician. If pregnant or nursing, take only on advice of physician. Keep this and all medication out of reach of children. Tamper resistant for your protection. Use only if safety seal is intact.

Caution: Federal Law prohibits dispensing without prescription.

Reference image forte.jpg

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medication out of reach of children.

Reference image forte.jpg

Indications and Usage

INDICATIONS & USAGE SECTION

Indication: Maintains the system under the stress of malignancy regardless of location. Targets tissues that tend to be more susceptible to cancer, neuralgias and dropsy of extremities, yellowed skin, headache, physical weakness and rheumatic pains.

Based on the homeopathic Materia  Medicas.

Reference image forte.jpg

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of label
Image of label


Bryomed, Inc.

210 Westcott

Houston, TX 77007

Questions call 714-785-4473

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
45984-0002-12020-01-31C16284748780-19d75b9d0-00cd-f424-e053-dadaa90a57ceNeobryXol Forte

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
45984-0002-1NeobryXol Forte30 mL in 1 BOTTLE, SPRAYLIQUID303

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
45984-0002NEOBRYXOL FORTE (ASTERIAS RUBENS, BRYONIA, CONIUM MACULATUM, GALIUM APARINE, HOANG-NAN, LACHESIS MUTUS, NUX VOMICA, OVA TOSTA, SEPIA AND VISCUM ALBUM) LIQUID [BRYOMED INC.]3Legacy NDC, 1 package rows20120410_f77e0d17-44de-4ac0-84a4-dcb3cb83cd33.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ASTERIAS RUBENSACTIVE INGREDIENTA7FYY9Q7423
BRYONIA ALBA ROOTACTIVE INGREDIENTT7J046YI2B3
CONIUM MACULATUM FLOWERING TOPACTIVE INGREDIENTQ28R5GF3713
EGG SHELL, COOKEDACTIVE INGREDIENT24HBF856C83
GALIUM APARINEACTIVE INGREDIENTZ4B65614883
LACHESIS MUTA VENOMACTIVE INGREDIENTVSW71SS07I3
SEPIA OFFICINALIS JUICEACTIVE INGREDIENTQDL83WN8C23
STRYCHNOS NUX-VOMICA SEEDACTIVE INGREDIENT269XH139193
STRYCHNOS WALLICHIANA BARKACTIVE INGREDIENTOQ16ZEE7O73
VISCUM ALBUM WHOLEACTIVE INGREDIENTE6839Q6DO13
ASTERIAS RUBENSACTIVE MOIETYA7FYY9Q7423
BRYONIA ALBA ROOTACTIVE MOIETYT7J046YI2B3
CONIUM MACULATUM FLOWERING TOPACTIVE MOIETYQ28R5GF3713
EGG SHELL, COOKEDACTIVE MOIETY24HBF856C83
GALIUM APARINEACTIVE MOIETYZ4B65614883
LACHESIS MUTA VENOMACTIVE MOIETYVSW71SS07I3
SEPIA OFFICINALIS JUICEACTIVE MOIETYQDL83WN8C23
STRYCHNOS NUX-VOMICA SEEDACTIVE MOIETY269XH139193
STRYCHNOS WALLICHIANA BARKACTIVE MOIETYOQ16ZEE7O73
VISCUM ALBUM WHOLEACTIVE MOIETYE6839Q6DO13
ALCOHOLINACTIVE INGREDIENT3K9958V90M3
WATERINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
45984-000245984-0002-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
NameUNIIKind
ASTERIAS RUBENSA7FYY9Q742ACTIB
BRYONIA ALBA ROOTT7J046YI2BACTIB
CONIUM MACULATUM FLOWERING TOPQ28R5GF371ACTIB
STRYCHNOS WALLICHIANA BARKOQ16ZEE7O7ACTIB
GALIUM APARINEZ4B6561488ACTIB
LACHESIS MUTA VENOMVSW71SS07IACTIB
STRYCHNOS NUX-VOMICA SEED269XH13919ACTIB
EGG SHELL, COOKED24HBF856C8ACTIB
SEPIA OFFICINALIS JUICEQDL83WN8C2ACTIB
VISCUM ALBUM WHOLEE6839Q6DO1ACTIB
WATER059QF0KO0RIACT
ALCOHOL3K9958V90MIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 59 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ALCOHOLALCOHOL3K9958V90MGEL / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MJELLY / VAGINALNAExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MMOUTHWASH / BUCCAL200 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / RECTAL898 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSYRUP / ORAL21000 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / ORAL6624 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / SUBLINGUAL397 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL, METERED / TOPICAL541 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / INTRAVENOUS400 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MPASTE / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / INTRAVENOUS99 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / ORAL150.68 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TOPICAL2445 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MPOWDER, FOR SOLUTION / TOPICAL40 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / INTRAMUSCULAR400 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL / NASAL20 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / ORAL210 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / DENTAL12.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MTABLET, DELAYED RELEASE / ORALNAExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / BUCCAL679 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSWAB / TOPICAL2250 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / RESPIRATORY (INHALATION)35.75 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, METERED / NASAL70 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / SUBCUTANEOUS6.1 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MELIXIR / ORAL13675 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAMUSCULAR1491 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, EMULSION / INTRAVENOUS520 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / INTRAVENOUS6405 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAVENOUS92 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / TRANSDERMAL7360 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLOTION / TOPICAL25 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / SUBCUTANEOUS149 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TOPICAL3633 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, FOAM / TOPICAL4504 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / INTRAVESICAL7892 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAVASCULAR100 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / INTRAVENOUS4000 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / INTRAMUSCULAR1000 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, METERED / RESPIRATORY (INHALATION)26664 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TRANSDERMAL90 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / RECTAL0.35 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY, METERED / SUBLINGUAL29 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / NASAL20 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL, METERED / TRANSDERMAL3675 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSHAMPOO / TOPICAL714 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / RESPIRATORY (INHALATION)0.08 %w/vExact identifier — unii candidate
59 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ea6128bb-29d8-4373-b6be-e1f24a6efb13f77e0d17-44de-4ac0-84a4-dcb3cb83cd332012-04-05WarningsExact identifier
spl id: ea6128bb-29d8-4373-b6be-e1f24a6efb13
spl set id: f77e0d17-44de-4ac0-84a4-dcb3cb83cd33

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.